| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/20/1995 | EP0672406A1 Composition based on alpha-pyrones for inducing and stimulating hair growth and/or inhibit loss, and its use |
| 09/20/1995 | EP0672250A1 A NOVEL $i(IN VITRO) METHOD OF SCREENING POTENTIAL ANTICANCER DRUGS USING A CELL DIFFERENTIATION ASSAY |
| 09/20/1995 | EP0672193A1 Oligonucleotides having a conserved g 4? core sequence |
| 09/20/1995 | EP0672192A1 Method for inhibition of viral morphogenesis |
| 09/20/1995 | EP0672180A1 Oligonucleotide modulation of protein kinase c |
| 09/20/1995 | EP0672160A1 Activating expression of an amplifying endogenous gene by homologous recombination |
| 09/20/1995 | EP0672158A1 Virus with modified binding moiety specific for the target cells |
| 09/20/1995 | EP0672153A1 Vector to deliver and express foreign gene |
| 09/20/1995 | EP0672151A1 Inhibitors of ced-3 and related proteins |
| 09/20/1995 | EP0672133A1 TNF-$g(a) RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-$g(a) RIBOZYMES |
| 09/20/1995 | EP0672119A1 Retroviral mediated transfer of the human multiple drug resistance gene |
| 09/20/1995 | EP0672047A1 ANTIALLERGIC IMIDAZO 1,2-a](PYRROLO, THIENO OR FURANO) 2,3-d]AZEPINE DERIVATIVES |
| 09/20/1995 | EP0672046A1 Spirofuranone derivatives and their use in the treatment of neurodegenerative disorders |
| 09/20/1995 | EP0672043A1 Novel 4-(3-benzofuranyl)piperidinyl and 4-(3-benzothienyl)piperidinyl derivatives and pharmaceutical compositions containing them |
| 09/20/1995 | EP0672042A1 Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof |
| 09/20/1995 | EP0672041A1 Pharmacologically active pyridine derivatives and processes for the preparation thereof |
| 09/20/1995 | EP0672040A1 Further pyrimidine derivatives and their preparation |
| 09/20/1995 | EP0672037A1 1,4-benzodiazepine derivatives and their use as cck-modulators |
| 09/20/1995 | EP0672036A1 Pharmaceutically active diketopiperazines |
| 09/20/1995 | EP0672035A1 Pyrimidineamine derivatives and processes for the preparation thereof |
| 09/20/1995 | EP0672034A1 Benzimidazole compounds which inhibit platelet aggregation |
| 09/20/1995 | EP0672032A1 Novel phenylethyl and phenylpropylamines |
| 09/20/1995 | EP0672031A1 Catechol diethers as selective pde iv? inhibitors |
| 09/20/1995 | EP0672030A1 Process for preparing substantially pure enantiomers of phenylpropionic acids. |
| 09/20/1995 | EP0671953A1 C-glycoside analogues of n-(4-hydroxyphenyl)retinamide-o-glucuronide |
| 09/20/1995 | EP0671952A1 Method for nonspecific cellular immune stimulation |
| 09/20/1995 | EP0671942A1 Medical use, a medical method and a pharmaceutical preparation |
| 09/20/1995 | EP0671936A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-$g(a) FUNCTION |
| 09/20/1995 | EP0671928A1 Synthesis of n-substituted oligomers |
| 09/20/1995 | EP0671924A1 Digitalis-like compounds |
| 09/20/1995 | EP0671919A1 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it |
| 09/20/1995 | EP0671917A1 Method for inhibition of cell motility by sphingosine-1-phosphate, its derivatives and mimetics and method of synthesizing sphingosine-1-phosphate and its derivatives |
| 09/20/1995 | EP0671916A1 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer |
| 09/20/1995 | EP0671915A1 Use of idazoxan and derivatives thereof in preparing a drug for treating parkinson's disease and its development |
| 09/20/1995 | EP0671914A1 Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds |
| 09/20/1995 | EP0671913A1 Antioxydant cardioprotective use of, and method of treatment using, hydroxycarbazole compounds |
| 09/20/1995 | EP0671912A1 Injectable taxane derivative based compositions |
| 09/20/1995 | EP0671911A1 Carboxy-peptidyl derivatives as antidegenerative active agents |
| 09/20/1995 | EP0671910A1 Glaucoma treatment |
| 09/20/1995 | EP0671909A1 Syndecan stimulation of cellular differentiation |
| 09/20/1995 | EP0671908A1 Pharmaceutical compositions comprising 5-ht 1? receptor agonists and absorption enhancers |
| 09/20/1995 | EP0671904A1 Antibiotic formulation and use for drug resistant infections |
| 09/20/1995 | EP0671879A1 Prevention of retinal injury and degeneration by specific factors |
| 09/20/1995 | EP0656795A4 Method for treating cardiovascular disease through adjunctive photodynamic therapy. |
| 09/20/1995 | EP0652972A4 Pseudo-half-knot rna formation by hybridization of antisense oligonucleotides to target rna's secondary structure. |
| 09/20/1995 | EP0614356B1 Transdermal estradiol delivery system |
| 09/20/1995 | EP0576475B1 Isoindoles having cardiovascular activity |
| 09/20/1995 | EP0563358B1 9-substituted bicyclo [3.3.0]octane derivatives, for use as txa2 antagonists |
| 09/20/1995 | EP0489877B1 Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones |
| 09/20/1995 | EP0479813B1 Novel methylenebisphosphonic acid derivatives |
| 09/20/1995 | EP0468012B1 17$g(b)-SUBSTITUTED-4-AZA-5$g(a)-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION |
| 09/20/1995 | EP0458965B1 Process for the preparation of vinyl ethers |
| 09/20/1995 | EP0364559B1 Substituted adenine derivatives useful as therapeutic agents |
| 09/20/1995 | CN1108694A 一种淡紫灰叶链霉菌dkrs菌株及用它制备阿克拉希霉素a，b，y和糖苷配基的方法 A lilac gray leaf dkrs Streptomyces strains and its preparation method Rashid Akbar ADM a, b, y and aglycone |
| 09/20/1995 | CN1108661A Corticoid 17,21-dicarboxylic esters and corticosteroid 17-carboxylic ester 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 09/20/1995 | CN1108658A Galanthamine derivatives, a process for their preparation and their use as medicaments |
| 09/20/1995 | CN1108657A Calanthamine derivatives, a process for their preparation and their use as medicaments |
| 09/20/1995 | CN1108655A 1,3-oxathiolane nucleoside analogues |
| 09/20/1995 | CN1108654A Methods of treating menstrual symtoms and compositions therefore |
| 09/20/1995 | CN1108653A 2-debenzoyl-2-acyl taxol deriatives and methods for making same |
| 09/20/1995 | CN1108651A Substituted 1-naphthyl-3-pyrazolecarboxamides which are actie on neurotensin, their preparation and pharmaceutical compositions containing them |
| 09/20/1995 | CN1108649A Noel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them |
| 09/20/1995 | CN1108648A Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them |
| 09/20/1995 | CN1108572A Antiulcer agent and adhesion inhibitor for helicobacter pyroli |
| 09/20/1995 | CN1108545A Quick blood-forming agent |
| 09/20/1995 | CN1108537A Housewife dermatitis treatment |
| 09/20/1995 | CN1108534A Synergistic gastrointestinal formulations |
| 09/20/1995 | CN1108533A Synergistic compositions for treating the skin |
| 09/20/1995 | CN1108532A 皮肤癌治疗 Skin Cancer Treatment |
| 09/20/1995 | CN1108531A Gastrointestinal cancer treatment |
| 09/20/1995 | CN1108530A Anti-biotic injection for animals and preparation method thereof |
| 09/20/1995 | CN1108529A Rapamycin formulations for oral administration |
| 09/20/1995 | CN1108528A Biologically actie dermatological treatment |
| 09/20/1995 | CN1108527A Synergistic compositions for hair restoration |
| 09/20/1995 | CN1108526A Gastrointestinal treatment |
| 09/20/1995 | CN1108525A Synergistic gastrointestinal cancer therapies |
| 09/20/1995 | CN1108524A Skin treatment |
| 09/20/1995 | CN1108523A Biologically actie health formulation |
| 09/20/1995 | CN1108522A Synergistic biologically actie skin moisturizer |
| 09/20/1995 | CN1108472A Solid insecticidal formulation |
| 09/20/1995 | CN1029771C Preparation for cantharidin fat-soluble preparation |
| 09/20/1995 | CN1029770C Controlled release bases for pharmaceuticals |
| 09/19/1995 | US5451700 Leukotriene inhibitors |
| 09/19/1995 | US5451690 Lambda-1,4-pregnadiene-3,20-diones |
| 09/19/1995 | US5451688 Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses |
| 09/19/1995 | US5451685 Substituted oxotremorine derivatives |
| 09/19/1995 | US5451677 Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity |
| 09/19/1995 | US5451676 Biphenyl ether heterobicyclic platelet activating factor antagonists |
| 09/19/1995 | US5451667 Sporicides, microbiocides |
| 09/19/1995 | US5451609 Deacetly moxisylyte |
| 09/19/1995 | US5451608 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovasular system, processes for their preparation and pharmaceutical compositions containing them |
| 09/19/1995 | US5451606 Anthraquinone compounds useful to treat osteoarticular conditions, pharmaceutical compositions and method of treatment |
| 09/19/1995 | US5451605 Treating skin disorders |
| 09/19/1995 | US5451603 Side effect reduction |
| 09/19/1995 | US5451602 Cholecystokinin antagonists useful in the treatment of panic attcks |
| 09/19/1995 | US5451601 Perhydroisoindole derivatives and pharmaceutical compositions containing them |
| 09/19/1995 | US5451599 Complex salts of hematoporphyrin and of its derivatives, their synthesis, and therapeutic agent |
| 09/19/1995 | US5451597 Treatment of circulatory disorders using n-substituted (α-imidazolyl-toluyl) pyrrole angiotensin II antagonists |
| 09/19/1995 | US5451596 Cycloalkyl amine bis-aryl squalene synthase inhibitors |
| 09/19/1995 | US5451592 Angiotensin antagonist |